Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors

Sorafenib, lenvatinib and regorafenib, the multi-RTK inhibitors with potent anti-angiogenesis effects, are currently therapeutic drugs generally recommended for the patients with advanced hepatocellular carcinoma (HCC). To date, however, there have been no published studies on the mechanism underlin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xuejiao, Zhang, Qingning, Guo, Wenyan, Wang, Lan, Wu, Tao, Zhang, Wei, Liu, Ming, Kong, Dezhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444053/
https://www.ncbi.nlm.nih.gov/pubmed/36071844
http://dx.doi.org/10.3389/fphar.2022.944893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444053/
https://www.ncbi.nlm.nih.gov/pubmed/36071844
http://dx.doi.org/10.3389/fphar.2022.944893

Ejemplares similares